For Patients and Visitors
For Students
For Medical Professionals
For Job Seekers
Welcome to Penn State Hershey Pediatric Hematology/Oncology

Penn State Hershey Hematology/Oncology at Penn State Hershey Children's Hospital provides comprehensive care to infants, children, adolescents and young adults with a variety of healthcare needs.

Care is provided using a multidisiplinary team approach with patient and family being at the center of the healthcare team. This special team extends beyond the hematology/oncology staff to include the expertise of many other pediatric specialists at Penn State Hershey Children’s Hospital.  A cohesive network forms to meet the complex needs of children and families affected by cancer or hematologic disorders.  Learn More >>>

The Four Diamonds Fund generously supports our oncology patients to defray costs not covered by standard insurance.  The fund provides extensive resources for our outpatient and inpatient units, and supports personel to assure the best outcomes for our patients. 

The Four Diamonds Fund has been actively involved in funding research conducted at Penn State College of Medicine through grants for projects relating to the causes, prevention, treatment,and cure for pediatric cancer.

In 1998, in an effort to expand their research potential, an initiative was launched to establish the Four Diamonds Pediatric Research Center at Penn State College of Medicine.  Thanks to the generosity of many donors, particularly the Penn State Dance Marathon, this Research Institute now has a $20 million dollar endowment.  Two endowed chairs have been established in support of childhood cancer research.  Division Chief Barbara Miller, MD holds the Christopher Millard Endowed chair, and Ken Lucas, MD is the director of stem cell transplant and holds the Penn State Dance Marathon Panhelleic Chair.

Recently, the Four Diamonds Fund has committed to a $10 million dollar endowment for the Four Diamonds Experimental Therapeutic Program, which is dedicated to promote the development of new therapies for children with cancer to improve cure rates and reduce side effects.

In addition to the basic scientific research that occurs within the labs of The Four Diamonds Research Center at Penn State College of Medicine, the Division of Pediatric Hematology/Oncology is actively involved in the management of clinical trials to treat childhood cancer.

As members of the Children's Oncology Group, the physicians and nurses are involved in the development and management of state-of-the-art protocols used internationally to treat children with cancer.  This provides our patients with access to the most advanced clinical trials available.  It is through this participation by institutions worldwide that the cure rates have improved from fatal diseases to ones that carry an 80% long term survival rate.

A new Experimental Therapuetics Program has recently been endowed to promote the development of new innovative therapies and initiation of clinical trials to improve outcomes.